Neuroendocrine and immune disequilibrium as a probable link between metabolic syndrome and carcinogenesis.

doi:10.1016/j.mehy.2018.05.018

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Neuroendocrine and immune disequilibrium as a probable link between metabolic syndrome and carcinogenesis.

Medical hypotheses - 1 Sept 2018

Hristova Mariyana G

Abstract excerpt

Numerous investigations prove a higher incidence of carcinogenesis in metabolic syndrome (MetS). They indicate the important role of obesity, elevated inflammatory biomarkers, hyperinsulinemia, hyperglycemia, and dyslipidemia as well. Elevated plasma insulin and free insulin-like growth factor-1 (IGF-1) levels stimulate cell proliferation. The present publication considers the role of neuroendocrine and immune...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adiponectin
Share to Catecholamines
Share to Estrogens
Share to Hydrocortisone

Source

Open in PubMed

Identifiers

PMID: 30037593
DOI: 10.1016/j.mehy.2018.05.018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immune System

Share to Mast Cells

Share to Nerve Growth Factors

Share to Neurosecretory Systems